Does RUCAPARIB CAMSYLATE Cause Flushing? 30 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Flushing have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 0.4% of all adverse event reports for RUCAPARIB CAMSYLATE.
30
Reports of Flushing with RUCAPARIB CAMSYLATE
0.4%
of all RUCAPARIB CAMSYLATE reports
1
Deaths
6
Hospitalizations
How Dangerous Is Flushing From RUCAPARIB CAMSYLATE?
Of the 30 reports, 1 (3.3%) resulted in death, 6 (20.0%) required hospitalization.
Is Flushing Listed in the Official Label?
Yes, Flushing is listed as a known adverse reaction in the official FDA drug label for RUCAPARIB CAMSYLATE.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Flushing Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE